Objective: To identify the clinical features of Japanese patients with suspected hereditary sensory and autonomic neuropathy (HSAN) on the basis of genetic diagnoses.
Hereditary sensory and autonomic neuropathy (HSAN) is a clinically and genetically heterogeneous group of disorders. Until now, HSAN has been classified into 6 main groups on the basis of their mode of inheritance and clinical features, and 11 HSAN disease-causing genes have been identified (table 1 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] .
SCN9A encodes the voltage-gated sodium channel (Na V 1.7), and the gain-of-function mutations result in several painful disorders, including inherited erythromelalgia, 18 paroxysmal extreme pain disorder, 19 and small nerve fiber neuropathy. 20 Loss-of-function SCN9A mutations have been linked to channelopathy-associated insensitivity to pain (CIP), which is characterized by congenital insensitivity to pain perception and anosmia; however, the autonomic dysfunction has been regarded as exclusionary criteria for the diagnosis of CIP. 21 It is noteworthy that no definite abnormalities have been recorded using either nerve conduction studies or sural nerve pathologic examinations in all of the previous cases with homozygous loss-of-function SCN9A mutations and part with compound heterozygous mutations. [22] [23] [24] [25] [26] However, a slight reduction in sensory nerve action potentials (SNAP) was recorded in two cases with compound heterozygous SCN9A mutations. 25, 27 In this study, using a next-generation sequencer, in 9 Japanese patients who were diagnosed with HSAN based on their clinical, in vivo electrophysiologic, and pathologic features, 11 known HSAN disease-causing genes and 5 related genes including SCN9A were screened. We identified a homozygous frameshift mutation in SCN9A of 2 patients/families. Therefore, we demonstrate that loss-of-function SCN9A mutation can produce a typical HSAN phenotype, and we propose this new classification as HSAN type IID. This study also broadened the spectrum of clinical phenotypes in patients with SCN9A-related disorders. Furthermore, on the basis of clinical, in vivo electrophysiologic, and pathologic findings, we attempted to elucidate the pathogenesis of the mutated Na V 1.7.
METHODS All patients who were referred to our department from 2000 to 2012 and who had sensory and autonomic nerve dysfunctions were selected. After excluding patients who had associated multiple motor nerve involvement, 9 patients were enrolled and genotyped in this study. Besides the 11 known HSAN disease-causing genes described above, we also investigated another 5 genes that might also cause sensory and autonomic symptoms, including SCN9A, CCT5, PRNP, FLVCR1, and RNF170.
The protocol of the following study was reviewed and approved by the Institutional Review Board of Kagoshima University. All patients and family members provided written informed consent to participate in this study.
Pathologic study. Sural nerve biopsies, performed at the age of 42 years in patient 1 and at the age of 25 years in patient 2, were analyzed according to standard morphologic procedures for light and electron microscopy. 28 A portion of the specimen was prepared for teased fiber analysis and classified according to Dyck's criteria. 29 The diameter and density of the myelinated fibers were analyzed with a Luzex AP image analyzer (Nireco Corporation, Tokyo, Japan).
Mutation sequencing. Genomic DNA was extracted from the peripheral blood leukocytes.
Using the Primer 3 program, we designed 375 oligonucleotide primers that covered all 357 coding exons and exon-intron junctions with amplicon lengths of 400-500 base pairs. Briefly, all target fragments of 9 patients were amplified by multiplex PCR (QIAGEN Multiplex PCR Kit; QIAGEN GmbH, Hilden, Germany) and ligated with specified indexes, respectively, then screened on the MiSeq sequencing system simultaneously in Table 1 Overview of HSAN Abbreviations: AD 5 autosomal dominant; AR 5 autosomal recessive; ATL1 5 atlastin GTPase 1; DNMT1 5 DNA (cytosine-5)-methyltransferase 1; DST 5 dystonin; FAM134B 5 family with sequence similarity 134, member B; IKBKAP 5 inhibitor of k light polypeptide gene enhancer in B cells, kinase complex-associated protein; Inh 5 inheritance; KIF1A 5 kinesin family member 1A; NGF 5 nerve growth factor (b polypeptide); NTRK1 5 neurotrophic tyrosine kinase, receptor, type 1; SPTLC1 5 serine palmitoyltransferase, long chain base subunit 1; SPTLC2 5 serine palmitoyltransferase, long chain base subunit 2; WNK1 5 WNK lysine deficient protein kinase 1.
accordance with the manufacturer's protocol. The results were mapped to the genome reference sequence in the CLC Genomics Workbench 4 (CLC Bio, Aarhus, Denmark) and then analyzed with tablet software. 30 The polymorphic and pathogenic natures of the confirmed variants were checked against the single nucleotide polymorphism database (dbSNP) (http://www.ncbi.nlm.nih.gov/snp/) and the 1000 Genomes database (http://browser.1000genomes.org/index.html). To confirm the suspected pathogenic mutations or low coverage domains (depth less than 10) in the MiSeq sequencing output, Sanger sequencing was also performed using the same methodology as the one employed in a previous study. 31 We screened 100 Japanese population control patients for the c.3993delGinsTT mutation.
RESULTS
Patients. Patient 1. This 50-year-old man was the sixth child from a consanguineous family. No abnormalities were noted at birth or in the early developmental stages except for slight hyposmia since childhood. Since primary school, pain perception started to decrease in his hands and feet. At 30 years of age, he underwent lumbar spinal fixation, but felt no pain. After 40 years of age, the numbness progressed from the distal to the proximal limbs. Furthermore, his toes could not perceive temperature well when he entered his bath, and while walking, his right slipper always slipped off. There was no history of episodes of unexplained vomiting or dysphagia. A detailed physical examination revealed multiple skin lesions, including a burn mark on the right middle finger, which was caused by a cigarette. No pupillary abnormalities were observed. His muscle strength was normal, except grade 41/5 weakness in the right tibialis anterior muscle. He also had a slight steppage gait. All reflexes were diminished, and his pathologic reflexes were negative. Pain and temperature perception were reduced in the distal limbs and absent in his feet. However, sense of vibration, joint position, and pressure were all preserved. Postural hypotension was excluded. During the sweating test, no sweating was observed in his face or any of his limbs, except in the palm of his left hand. Asymptomatic sensorineural hearing loss with an increase in the 4,000-Hz threshold in the left ear was diagnosed by an otorhinolaryngologist. MRI of the brain was normal.
In nerve conduction study, all motor nerve conduction velocity and compound muscle action potentials (CMAP) values were normal, except for a slightly reduced CMAP in the right tibial nerve at 3.5 mV (normal range, .4.4 mV). Sensory nerve conduction velocity (SCV) was slightly slow in the right median and ulnar nerve at 45.2 m/s (normal range, .47.2 m/s) and 40 m/s (normal range, .46.9 m/s), respectively, and moderately slow in the right sural nerve at 27.5 m/s (normal range, .40.8 m/s). SNAP amplitudes were markedly reduced in the right median nerve (0.9 mV; normal range, .7.0 mV), bilateral ulnar nerves (1.3 and 2.2 mV; normal range, .6.9 mV), and the right sural nerves (1.0 mV; normal range, .5.0 mV). However, the SCV and SNAP in the left median nerve were normal. Patient 2. This 33-year-old man was from a nonconsanguineous family having no history of neurologic disorders. Decreased pain and temperature perception was noted at birth. When he was a year old, his feet were burnt after he walked on asphalt on a hot summer day, and this eventually progressed to osteomyelitis. Subsequently, he underwent operations of the right tibia and both feet, but he could not feel any pain. Before enrolling in primary school, hearing loss in the left ear and hyposmia were detected. He experienced occasional urinary and fecal incontinence, and frequent urination at night. His height was 157 cm, and he had a short humerus (27.5 cm) and right hallux ( figure 1, B and C). Left acetabular dysplasia was noticed, which contributed to his left lower limb being 3 cm longer than his right lower limb. Rash and pigmentation were scattered over his chest and back ( figure 1B) , and several painless ulcers and deformed joints were observed in his fingers ( figure 1D ). Tendon hyperreflexia was noted in the lower limbs, and pathologic reflexes were negative. Pain perception was impaired in a glove-stocking pattern. Sense of vibration, joint position, and pressure were all normal. The sweating test revealed reduced sweating tendency throughout the body and especially in the trunk, except for his hands and feet. Postural hypotension was excluded, and brain MRI was normal. A lacrimal secretion anomaly was also detected. Otorhinolaryngologic examinations revealed the following:
deafness in the left ear and minimal hearing loss in the right ear, glossopharyngeal and chorda tympani nerve abnormalities in the gustatory sensation test, reduced number of fungiform papilla on his tongue ( figure 1A) , and a decline in olfactory acuity as tested by a jet stream olfactometer. Examinations of the urinary tract excluded any organic disease. The nerve conduction study revealed all motor nerve conduction velocity and CMAP values within normal ranges. The SCV was slightly slow in the right median and ulnar nerves (45.2 m/s and 46.2 m/s, respectively). However, SNAP was moderately decreased in the bilateral median (7 and 5.7 mV) and ulnar (3.3 and 4.4 mV) nerves. Nevertheless, no abnormalities were detected in sural nerve SCV and SNAP values.
Patient 3. This 55-year-old woman was an elder sister of patient 1. Her pregnancy was uneventful and delivery was normal. She had recurrent fractures and underwent operations for the left thigh (at age of 3 years and 8 years), right thigh (at age 11 years), and left elbow (primary school). When she was 30 years old, she perceived no pain after her feet were burnt on a heater. Anhidrosis was also noted, but after the age of 45 years, occasional sweat was secreted on her back. There was no evident hyposmia or hearing loss. At present, she is able to stand up and walk using her hands for support. Cranial nerve examinations were normal. Deformities of the left elbow, right foot, and bilateral lower limbs were noted. Muscle strength testing was normal in the upper limbs, whereas the strength in the lower limb muscles decreased to grades 2/5-4/5. Pain and temperature perceptions were reduced in the distal lower limbs and the anterior part of the right thigh, which may have been involved because of damage from surgery. The sense of vibration and joint position were preserved. Reflexes in her lower limbs were absent, and her pathologic reflexes were negative. Osteoporosis was excluded by an orthopedist. The clinical courses of the 3 patients described above, including the onset and imaged severities of each symptom, are shown in figure 2 .
Pathologic studies. In patient 1, the number of myelinated fibers was markedly decreased in all fasciculi, but the changes varied in their scale and extent. A histogram of the fiber diameter indicated a marked loss of large myelinated fibers relative to small myelinated fibers. Some remaining myelinated fibers had thinner myelin sheaths and some exhibited axonal degeneration. An electron microscopic study revealed clusters of Schwann cell processes, which may have been caused by the axonal degeneration of unmyelinated fibers ( figure 3A) . Contrary to the findings in patient 1, the number of myelinated fibers in patient 2 was slightly decreased, even with marked clinical symptoms. The histogram of fiber diameter showed a normal pattern. Electron microscopy showed that unmyelinated fibers were fairly preserved (figure 3B). No demyelinated fibers or inflammatory cells could be found in either patient.
Genetic studies. Using the MiSeq sequencing system, all of the 9 patients were genotyped successfully. Besides patients 1 and 2, no pathogenic mutation was detected. The CLCbio software showed that 96.24% and 93.6% of the data matched the reference sequences in patients 1 and 2, respectively. In the 357 targeted exons, 98.04% and 97.76% covered more than 10 reads. From patients 1 and 2, a total of 41 high-confidence variants were detected (table e-1 on the Neurology ® Web site at www.neurology.org). In these variants, 39 known SNPs were coincident with the dbSNP or 1000 Genome database. Of the remaining 2 variants, the c.3248A.C in KIF1A was found in normal controls and was therefore considered as an SNP. A homozygous mutation in exon 22 of SCN9A, c. 3993delGinsTT, remained. This mutation was not observed in 100 Japanese control patient samples, Figure 3 Pathologic findings from the sural nerve biopsies
In patient 1, the density of large and small myelinated fibers is markedly decreased. The remaining myelinated fibers have thinner myelin sheaths. Some teased fibers exhibit axonal degeneration. The histogram of the fiber diameter indicates loss of large myelinated fibers (5,343 fibers/mm 2 ). Electron microscopic examination shows clusters of Schwann cell processes (A). In patient 2, the densities of large and small myelinated fibers are slightly decreased. Teased fibers exhibit shortened internodal remyelination. The histogram of the fiber diameter shows a normal pattern (8,611 fibers/mm 2 ). Unmyelinated fibers are fairly preserved, as shown under the electron microscope (B).
nor did we find it on the 1000 Genomes Web site, which catalogs human genetic variations using 2,500 patient samples, including 500 East Asian (100 Japanese) patient samples. DNA samples were then collected from 3 other family members of pedigree 1, and 2 members of pedigree 2. In patient 3, the same genotype was identified. In addition, asymptomatic carriers (mother and another elder sister of patient 1 and the mother of patient 2) and an unaffected member (brother of patient 2) were found ( figure  4, A and B) . This mutation changes the reading frame during the translation of the mRNA and generates a premature stop codon ( figure 4C) .
DISCUSSION Among the 16 disease-causing or related genes of HSAN, we identified a homozygous mutation in SCN9A from 2 Japanese families. We described 3 patients who presented with new clinical, in vivo electrophysiologic, and pathologic phenotypes. SCN9A, which is located on chromosome 2q24.3, contains 26 coding exons. 32 It encodes Na v 1.7, which is the a-subunit of a tetrodotoxin-sensitive, voltage-gated sodium channel. Na v 1.7, composed of 4 domains, each with 6 transmembrane domains and 2 highly conserved pore-forming segments, 33 is preferentially expressed within the dorsal root ganglion and sympathetic ganglion neurons and their small-diameter peripheral axons. 34 It is crucial for the depolarizing phase of neuronal action potentials, and it seems to determine the excitability and repetitive firing properties of neurons. 35 Gain-of-function SCN9A mutations result in hyperexcitable nociceptive neurons and states, such as inherited erythromelalgia, 18 paroxysmal extreme pain disorder, 19 and small nerve fiber neuropathy, 20 whereas loss-of-function SCN9A mutations produce no sodium current and generate CIP. 22 In our study, both families lived in the Kagoshima prefecture, which is located to the south of Kyushu Island, Japan, and both were unrelated to each other. Loss of pain and temperature perceptions began at different ages, appearing as early as birth in patient 2, in the second decade in patient 1, and in the third decade in patient 3. Their ages at the onset of symptoms were different from those reported for patients with CIP who had a congenital onset. Moreover, in these 3 patients, the area of their pain insensitivities was limited mainly within the distal part of the limbs, not the entire body, as is seen in patients with CIP. The sense of vibration and joint position were preserved in our patients. However, the predominant reduction in sweat production in our 3 patients, together with urination and defecation disorder, lacrimal secretion anomaly, and decreased number of fungiform papilla on the tongue in patient 2, suggested autonomic nervous system dysfunction. A recent study indicated that Na v 1.7 in sympathetic neurons also contributes to the sensation of neuropathic pain. 36 The severe rash and pigmentation may be due to a post-inflammatory hyperpigmentation, resulting from the disruption of autonomic innervation. Meanwhile, hyposmia/anosmia, which is a common feature in patients with CIP and loss-of-functional SCN9A mutation, 23, 27, 37 was also identified in our patients. Furthermore, in patient 2, hypogeusia was detected using a gustatory sensation test. Bone dysplasia, as an additional symptom in patient 2 (acetabular dysplasia, short humerus, and right hallux), had also been reported in a Dutch kindred. 38 The otorhinolaryngologist confirmed hearing loss, although at different levels, in patients 1 and 2, which has mainly been recorded in patients with HSAN type IE. [4] [5] [6] These findings definitely broaden the symptomatic heterogeneity of SCN9A mutations.
Although pain insensitivity was symmetrically detected in the distal portion of the limbs of the 2 index patients, nerve conduction studies only revealed asymmetric involvement of the extremities. These findings, except those of the peroneal nerve, were compatible with sensory-predominant axonal multiple mononeuropathy complicated by minimal demyelinating changes, rather than a polyneuropathy.
Interestingly, the pathologic features of the sural nerve in the 2 index cases also varied. Although decreases in the small and large myelinated fibers were observed among the fasciculi in patient 1, the extent was dramatically different, whereas the density of small and large myelinated fibers was fairly preserved in patient 2. These discoveries were consistent with the nerve conduction study findings, which suggested a mismatch between the distribution of affected fibers and the severity of the loss-of-pain sensations. In addition, especially in patient 1, both decreased large myelinated fibers and decreased SNAP/SCV indicated that the large myelinated fibers were affected, whereas cases with gain-of-function SCN9A mutations always present with small myelinated and unmyelinated fiber abnormalities. 20 The selective involvement of sensory nerves in these patients is inconsistent with the clinical features and may indicate that the dysfunction of the dorsal root ganglion is more predominant than that of the peripheral nerve. However, the mechanisms underlying the pathologic aberrations in the fasciculi or nerves, caused by the mutated Na v 1.7 in the dorsal root ganglion, require further research.
The homozygous mutation, c.3993delGinsTT, which is located in exon 22 of SCN9A, is expected to shift the reading frame from amino acid 1331 (p. leu1331phe) and generate a premature stop codon. This will induce an essential alteration in the fifth transmembrane segment of domain 3 in Na v 1.7 and eliminate the whole fourth domain. The nonsense-mediated messenger RNA decay mechanism will then be activated, which will induce loss of function of Na v 1.7 in nociceptive neurons. Together with the pedigree study that confirmed the cosegregation of the genotype and phenotype, this mutation was believed to be a pathogenic mutation.
In 3 patients from 2 Japanese families who experienced symptoms that were characterized by congenital or adolescence-onset loss of pain and temperature perception and autonomic nervous dysfunction accompanied by hyposmia, hearing loss, hypogeusia, bone dysplasia, and fractures, we identified a novel loss-of-function frameshift SCN9A mutation. We demonstrated that this was a new entity on the basis of clinical, in vivo electrophysiologic, and pathologic findings. We introduce this new entity as HSAN type IID, an allelic disorder with CIP, both of which result from loss-of-function mutations in SCN9A. Furthermore, on the basis of in vivo electrophysiologic and pathologic findings, we furthered the understanding of the mechanisms induced by the loss of function of Na v 1.7. We are able to summarize that a loss-of-function SCN9A mutation can produce heterogeneous phenotype, even harboring the same mutation.
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